Avail Bio
Founded 2018 · 2 employees on LinkedIn · 2 known investors
Data and software platform to better understand the immune system
Also known as Avail Bio Inc.
Founders & leadership
Investors · 2
Company profile
researched Aug 2026Avail Bio is a genomic biotechnology company based in San Francisco, California, founded in 2018. It applies proprietary genomic platform technologies to immune therapeutic discovery, with a scientific team supported by Illumina Inc. and academic disease experts.
The company has also been described as a precision medicine oncology startup working to optimize patient response to cancer therapeutics while minimizing the risk of adverse events. Reported headcount figures vary across listings, ranging from 1-10 to 11-50 employees. Its address is listed as 665 3rd Street, Rm 250, San Francisco, CA 94107.
Business model
The company operates as a venture-backed biotechnology firm developing proprietary genomic platform technologies for therapeutic discovery, working with an equipment/technology partner and academic disease experts rather than selling a standalone consumer product.
Traction
Listed as venture-backed with two named investors, Fifty Years and Hawktail, and an entry dated 13 May 2022; a directory listing recorded the company as active as of that date.
▸Full profile — market position, technology, go-to-market, geography
Market position
A privately held, venture-backed early-stage biotechnology company in the San Francisco Bay Area, categorized in biotechnology, research and platform segments.
Avail Bio positions itself around proprietary genomic platform technologies applied to immune therapeutic discovery, developed with support from Illumina Inc. and academic disease experts.
Technology
Proprietary genomic platform technologies used for immune therapeutic discovery, developed with support from Illumina Inc. and academic disease experts.
Go-to-market
Cancer patients and therapeutic development, via work aimed at optimizing patient response to cancer therapeutics and reducing adverse events.
Geography
Headquartered in San Francisco, California, United States, with an address at 665 3rd Street, Rm 250, San Francisco, CA 94107.
Compiled by commissioned research from 5 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
▸Research sources · 5
primary sources listed
- Avail Bio – Funding, Valuation, Investors, Newsparsers.vc · web
5 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Avail Bio do?
- San Francisco genomic biotechnology company applying proprietary platform technologies to immune therapeutic and precision oncology discovery.
- Who are Avail Bio's investors?
- Avail Bio's investors include Fifty Years, HAWKTAIL.